Prentiss Smith & Co’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-530
Closed -$34K 262
2017
Q2
$34K Buy
+530
New +$33.3K 0.02% 136
2016
Q1
Sell
-6,202
Closed -$542K 351
2015
Q4
$542K Sell
6,202
-169
-3% -$14.5K 0.29% 47
2015
Q3
$516K Sell
6,371
-915
-13% -$79.7K 0.29% 46
2015
Q2
$648K Buy
7,286
+35
+0.5% +$3.06K 0.32% 46
2015
Q1
$629K Sell
7,251
-1,081
-13% -$90.7K 0.3% 47
2014
Q4
$705K Buy
8,332
+7,932
+1,983% +$620K 0.33% 47
2014
Q3
$28K Hold
400
0.01% 139
2014
Q2
$28K Hold
400
0.01% 144
2014
Q1
$30K Hold
400
0.02% 146
2013
Q4
$28K Hold
400
0.01% 147
2013
Q3
$25K Hold
400
0.01% 154
2013
Q2
$25K Buy
+400
New +$24.1K 0.01% 158

Other funds holding ESRX

Prentiss Smith & Co's ESRX Position: Q3 2017 in Review

Prentiss Smith & Co sold out of Express Scripts Holding Company (ESRX) in Q3 2017, closing a stake of 530 shares — an estimated $34K sold.

Prentiss Smith & Co first reported a position in ESRX in Q2 2013 and held it in 12 quarters. The position peaked at $705K in Q4 2014. 1,034 funds tracked by Wall St. Rank hold ESRX as of Q3 2017.

  • Prentiss Smith & Co reported no remaining Express Scripts Holding Company position as of Q3 2017 after selling out during the quarter.
  • Prentiss Smith & Co sold 530 Express Scripts Holding Company shares in Q3 2017, an estimated $34K.
  • Prentiss Smith & Co first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 12 quarters.
  • Prentiss Smith & Co's Express Scripts Holding Company position peaked at $705K in Q4 2014.
  • 1,034 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2017.

Based on Prentiss Smith & Co's 13F filing for Q3 2017, filed 23 Oct 2017.